Adagene
ADAG
10 hedge funds and large institutions have $6.16M invested in Adagene in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
2% more capital invested
Capital invested by funds: $6.02M → $6.16M (+$149K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.03% less ownership
Funds ownership: 7.51% → 7.49% (-0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$68.4K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$9.24K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SVI
Strategic Vision Investment
Hong Kong
|
-$72.4K |
| 2 |
Renaissance Technologies
New York
|
-$27K |
ADAG Hedge Fund Activity: Q3 2023 in Review
10 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q3 2023, worth a combined $6.16M — up 2.5% from $6.02M a quarter earlier.
Fund positioning in ADAG was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $68.4K. The largest seller was Strategic Vision Investment, cutting an estimated $72.4K.
- 10 institutional investors held Adagene (ADAG) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $6.16M of Adagene stock for Q3 2023, up 2.5% quarter-over-quarter.
- 1 fund opened new Adagene positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Adagene buyer in Q3 2023 was Morgan Stanley, an estimated $68.4K added.
- The largest Adagene seller in Q3 2023 was Strategic Vision Investment, an estimated $72.4K sold.
Based on aggregated 13F filings for Q3 2023.